Results 101 to 110 of about 11,965 (231)

The Beneficial Effect of Anticoagulation in Aortic Bioprosthesis is Associated with its Size

Brazilian Journal of Cardiovascular Surgery
Objective: To evaluate the clinical and echocardiographic outcomes in aortic valve replacement (AVR) patients with aortic bioprosthesis under oral anticoagulation (OA). Methods: Patients who underwent AVR with bioprosthesiswere prospectively enrolled.
Victor Dayan, Paula Farachio, Maria Jose Arocena, Amparo Fernandez, Diego Perez, Gerardo Soca   +5 more
doaj   +1 more source

Neo Left Main Channel Creation Using Double Stenting Alongside a Sapien 3 Aortic Valve Bioprosthesis for Left Main Coronary Obstruction Following Valve-in-Valve Transcatheter Aortic Valve Replacement: A Case Report With Review of Literature

Journal of Investigative Medicine High Impact Case Reports, 2018
Transcatheter aortic valve replacement in the setting of failed surgical bioprosthesis (valve-in-valve) is a valuable option for patients with bioprosthetic aortic stenosis or regurgitation who are deemed high risk for repeat open heart surgery. Although
Apurva D. Patel MD, MPH, Thomas Haldis DO, Kais Al Balbissi MD, Timir Paul MD, PhD   +3 more
doaj   +1 more source

Comparaison des résultats opératoires des remplacements valvulaires aortiques avec la nouvelle valve biologique intuity et la valve perimount [PDF]

, 2015
Introduction La sténose aortique est une affection courante, actuellement classée comme la troisième pathologie cardiaque par ordre de fréquence. Actuellement, la seule technique curative est le traitement chirurgical à l'aide de valves biologiques ou ...
RODUIT, C
core  

Transcatheter pulmonary valve in failed bioprosthesis [PDF]

Annals of Cardiothoracic Surgery, 2021
Dhaval R, Parekh, Athar M, Qureshi
openaire   +3 more sources

Editorial: Structural Valve Degeneration and Failure in Transcatheter and Surgical Bioprosthesis

Frontiers in Cardiovascular Medicine, 2020
Chiara Fraccaro, Darren Mylotte, Massimo Napodano   +2 more
doaj   +1 more source

Prognostic value of the ratio between prothesis area and indexed annulus area measured by multiSlice-CT for transcatheter aortic valve implantation procedures [PDF]

, 2016
Background Postprocedural aortic regurgitations following transcatheter aortic valve implantation (TAVI) procedures remain an is- sue. Benefit of oversizing strategies to prevent them isn’t well established.
Bical A, Delhaye C, Derby N, Elquodeimat I, FATTOUCH, Khalil, Koussa M, Modine T., Schurtzy G, Sudre A   +8 more
core  

On-pump fibrillating heart mitral valve replacement with the SAPIEN™ XT transcatheter heart valve [PDF]

, 2017
In some high-risk patients, standard mitral valve replacement can represent a challenging procedure, requiring a risky extensive decalcification of the annulus. In particular, high-risk redo patients and patients with a previously implanted transcatheter
Ferrari, Enrico, Locca, Didier, Marcucci, Carlo, Niclauss, Lars   +3 more
core  

Supra‐Annular Versus Intra‐Annular Devices for Transcatheter Aortic Valve‐in‐Valve Replacement: The PANDORA International Registry

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Background As transcatheter aortic valve replacement (TAVR) expands to younger, lower‐risk populations, the need for repeat procedures due to valve degeneration is expected to increase.
Antonio Popolo Rubbio, Antonio Sisinni, Enrico Criscione, Enrico Poletti, Nicolas Van Mieghem, Gaspare S. Cannone, Didier Tchétché, Azeem Latib, Andrea Scotti, Ole De Backer, Michele Morosato, Damiano Regazzoli, Ignacio A. Santos, Michiel Voskuil, Matjaz Bunc, David Hildick‐Smith, Joachim Schofer, Christina Brinkmann, Kush P. Patel, Andreas Baumbach, Francesco Bedogni, Luca Testa   +21 more
doaj   +1 more source

Outcome of bioprosthetic valve replacement in dogs with tricuspid valve dysplasia [PDF]

, 2017
Adin, Arai, Attenhofer Jost, Bloomfield, Brennan, Famula, Funayama, Griffiths, Liu, Massel, Monnet, Nakayama, Oliveira, Orton, Orton, Uechi   +15 more
core   +2 more sources

Clinical experience with the ATS 3f Enable® Sutureless Bioprosthesis [PDF]

, 2017
Objective: The ATS 3f Enable® Bioprosthesis is a self-expanding valve with a tubular design that allows for decreased leaflet stress and preservation of aortic sinuses. We report the midterm results of a prospective, multicenter clinical study evaluating
Bartus, Krzysztof, Carrel, Thierry, Eckstein, Friedrich S., Kapelak, Boguslaw, Martens, Sven, Sadowski, Jerzy, Schlensak, Christian, Sievers, Hans-Hinrich   +7 more
core